Cargando…

Estimation of TGF-β1 genotypes in Egyptian smokers; association with FEV(1) in COPD patients

INTRODUCTION: TGF-β1 is a cytokine with many different effects on cell proliferation, differentiation and inflammation and can protect against the development of COPD. This work aims to study the association between COPD and the TGF-β1 gene genotypes. MATERIAL AND METHODS: The study included 70 male...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bohy, Mohammad El, Ahmed, Mona, Ezzeldin, Nada, Ezzeldin, Howayda, Mahmoud, Mohamed, Shehata, Abeer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2010
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278946/ https://www.ncbi.nlm.nih.gov/pubmed/22371723 http://dx.doi.org/10.5114/aoms.2010.13510

Ejemplares similares

Association of TNF-α –308G/A, SP-B 1580 C/T, IL-13 –1055 C/T gene polymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population
por: Ezzeldin, Nada, et al.
Publicado: (2012)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Diagnosis, assessment, and phenotyping of COPD: beyond FEV(1)
por: Lange, Peter, et al.
Publicado: (2016)

COPD assessment test and FEV(1): do they predict oxygen uptake in COPD?
por: Carvalho-Jr, Luiz Carlos S, et al.
Publicado: (2018)

Diagnostic errors in Dentistry, opinions of egyptian dental teaching staff, a cross-sectional study
por: El-Wakeel, Naglaa, et al.
Publicado: (2022)

Characteristics of COVID and post COVID polyneuropathies in adults and pediatrics: an Egyptian sample
por: Elshebawy, Haidy, et al.
Publicado: (2021)

Genetic polymorphisms of human cytochrome P450 CYP1A1 in an Egyptian population and tobacco-induced lung cancer
por: Ezzeldin, Nada, et al.
Publicado: (2017)

Inflammatory and immunological profiles in patients with COPD: relationship with FEV (1) reversibility
por: Queiroz, Cleriston Farias, et al.
Publicado: (2016)

Low FEV1 Is Associated With Increased Risk Of Cachexia In COPD Patients
por: Mokari-Yamchi, Amin, et al.
Publicado: (2019)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Kakavas, Sotirios, et al.
Publicado: (2021)

FVC, but not FEV(1,) is associated with clinical outcomes of asthma-COPD overlap
por: An, Tai Joon, et al.
Publicado: (2022)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Retrospective Analysis of the Relationship between Decline in FEV(1) and Abdominal Circumference in Male Smokers: the Takahata Study
por: Sato, Masamichi, et al.
Publicado: (2012)

Longitudinal FEV(1) and Exacerbation Risk in COPD: Quantifying the Association Using Joint Modelling
por: Zhudenkov, Kirill, et al.
Publicado: (2021)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

FEV(1) inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure
por: Montaño, Martha, et al.
Publicado: (2014)

A novel CT-emphysema index/FEV(1) approach of phenotyping COPD to predict mortality
por: Loh, Li-Cher, et al.
Publicado: (2018)

Changes in FEV(1) over time in COPD and the importance of spirometry reference ranges: the devil is in the detail
por: Kirkby, Jane, et al.
Publicado: (2019)

Genome organization and molecular characterization of the three Formica exsecta viruses—FeV1, FeV2 and FeV4
por: Dhaygude, Kishor, et al.
Publicado: (2019)

Sclerodactyly and Diabetic Complications among Egyptian Adolescent Type 1 Diabetic Patient
por: El Dayem, Soha M. Abd, et al.
Publicado: (2019)

Utility of FEV(1)/FEV(6) index in patients with multimorbidity hospitalized for decompensation of chronic diseases
por: Komal, Shakeel, et al.
Publicado: (2019)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Annual FEV(1) changes and numbers of circulating endothelial microparticles in patients with COPD: a prospective study
por: Takahashi, Toru, et al.
Publicado: (2014)

Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV(1) in COPD patients
por: Huang, Cuiping, et al.
Publicado: (2013)

Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study
por: Zendedel, Abolfazl, et al.
Publicado: (2015)

Longitudinal change of FEV(1) and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD
por: Jo, Yong Suk, et al.
Publicado: (2019)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
por: Rosso, Aldana, et al.
Publicado: (2022)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Joint longitudinal model-based meta-analysis of FEV(1) and exacerbation rate in randomized COPD trials
por: Llanos-Paez, Carolina, et al.
Publicado: (2023)

Bicanalicular Annular Stent Compared with Bicanalicular Nasal Intubation in Management of Traumatic Lower Canalicular Laceration
por: Mansour, Hosam Othman, et al.
Publicado: (2022)

Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV(1)
por: Cane, Jennifer, et al.
Publicado: (2021)

Forced Expiratory Volume in 6 s (FEV(6)) and FEV(1)/FEV(6) Values as a Viable Alternative for Forced Vital Capacity (FVC) and FEV(1)/FVC Values During Pregnancy in South East Nigeria: A Preliminary Study
por: Nwagha, U, et al.
Publicado: (2014)

Vessel-Associated Transforming Growth Factor-Beta1 (TGF-β1) Is Increased in the Bronchial Reticular Basement Membrane in COPD and Normal Smokers
por: Soltani, Amir, et al.
Publicado: (2012)

Precision in Diagnosing and Classifying COPD: Comparison of Historical Height with Current Height and Arm Span to Predict FEV(1)
por: Ansari, Khalid, et al.
Publicado: (2012)

Finding the Best Thresholds of FEV(1) and Dyspnea to Predict 5-Year Survival in COPD Patients: The COCOMICS Study
por: Almagro, Pere, et al.
Publicado: (2014)

Treatment response in COPD: does FEV(1) say it all? A post hoc analysis of the CRYSTAL study
por: Kostikas, Konstantinos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h95hnlk426307t96sj05llr3kg